Overview
- Authors:
-
-
John S. Strauss
-
Yale University School of Medicine, New Haven, USA
-
William T. Carpenter
-
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, USA
Access this book
Other ways to access
Table of contents (12 chapters)
-
-
- John S. Strauss, William T. Carpenter Jr.
Pages 1-7
-
- John S. Strauss, William T. Carpenter Jr.
Pages 9-17
-
- John S. Strauss, William T. Carpenter Jr.
Pages 19-42
-
- John S. Strauss, William T. Carpenter Jr.
Pages 43-55
-
- John S. Strauss, William T. Carpenter Jr.
Pages 57-68
-
- John S. Strauss, William T. Carpenter Jr.
Pages 69-76
-
- John S. Strauss, William T. Carpenter Jr.
Pages 77-114
-
- John S. Strauss, William T. Carpenter Jr.
Pages 115-136
-
- John S. Strauss, William T. Carpenter Jr.
Pages 137-161
-
- John S. Strauss, William T. Carpenter Jr.
Pages 163-196
-
- John S. Strauss, William T. Carpenter Jr.
Pages 197-205
-
- John S. Strauss, William T. Carpenter Jr.
Pages 207-211
-
Back Matter
Pages 213-220
About this book
When Ifirst read this manuscript, Iexclaimed to a colleague: "This is the most important and clinically relevant book on schizophrenia since Bleuler!" Time has not altered my initial enthusiastic evaluation. Drs. Strauss and Carpenter are among the most distinguished researchers in the field ofschizophrenia,butthey are also clinicians ofgreat experience, breadth, sensitivity, and flexibility. It is from this expertise, as well as theirwide familiarity with the world literature, thattheyhavebeenable to distill the essence of an exceedingly practical and comprehensive approach to the understanding, evaluation, diagnosis, and treatment of schizophrenia. They begin by unequivocally stating the inadequacy and futility of approaching schizophrenia via a single model. Standingalone, neither a biomedical, a social, nor a psychological model can adequately account for the complexities of this illness with regard to etiology, phenomenol ogy, course, or optimum treatment. While the advent of psychophar macologicalinterventionhas made a profound impact on both individual treatment and the responsive support systems, and is an important aspect ofmosttreatmentplans, to view schizophrenia as a phenothiazine deficiency disease is not only bad science but bad therapeutics. Their conceptualization of an "interactive developmental systems model" provides a framework upon which to build a broad medical approach to schizophrenia. This model relates variables drawn from different systems, interactive with one another, and contributing to a pathogenetic process across time. Within this bio-social-psychological matrix, one can then organize information relative to vulnerability, the manifest illness per se, the course of the disorder, and the multiplicity of factors relative to treatmentplanning.
Authors and Affiliations
-
Yale University School of Medicine, New Haven, USA
John S. Strauss
-
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, USA
William T. Carpenter
